ING Group’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-47,412
| Closed | -$4.71M | – | 550 |
|
|
2019
Q3 | $4.71M | Sell |
47,412
-155,865
| -77% | -$14.8M | 0.12% | 126 |
|
|
2019
Q2 | $18.8M | Buy |
203,277
+16,706
| +9% | +$1.59M | 0.33% | 61 |
|
|
2019
Q1 | $17.6M | Buy |
186,571
+15,157
| +9% | +$1.33M | 0.38% | 52 |
|
|
2018
Q4 | $11M | Sell |
171,414
-31,815
| -16% | -$2.35M | 0.24% | 74 |
|
|
2018
Q3 | $18.2M | Buy |
203,229
+109,292
| +116% | +$9.66M | 0.31% | 60 |
|
|
2018
Q2 | $7.46M | Sell |
93,937
-89,500
| -49% | -$7.43M | 0.14% | 90 |
|
|
2018
Q1 | $16.4M | Buy |
183,437
+30,022
| +20% | +$2.88M | 0.3% | 59 |
|
|
2017
Q4 | $16M | Buy |
153,415
+150,412
| +5,009% | +$17M | 0.27% | 53 |
|
|
2017
Q3 | $438K | Sell |
3,003
-172,134
| -98% | -$23.4M | 0.01% | 540 |
|
|
2017
Q2 | $22.7M | Sell |
175,137
-3,586
| -2% | -$439K | 0.44% | 37 |
|
|
2017
Q1 | $22.2M | Sell |
178,723
-4,932
| -3% | -$590K | 0.4% | 49 |
|
|
2016
Q4 | $21.5M | Buy |
183,655
+23,019
| +14% | +$2.56M | 0.4% | 51 |
|
|
2016
Q3 | $16.5M | Buy |
160,636
+152,586
| +1,895% | +$16.5M | 0.2% | 71 |
|
|
2016
Q2 | $794K | Sell |
8,050
-1,310
| -14% | -$136K | 0.01% | 277 |
|
|
2016
Q1 | $937K | Sell |
9,360
-237,205
| -96% | -$24.4M | 0.01% | 297 |
|
|
2015
Q4 | $29.5M | Buy |
246,565
+55,756
| +29% | +$6.45M | 0.18% | 138 |
|
|
2015
Q3 | $20.6M | Sell |
190,809
-52,679
| -22% | -$6.54M | 0.14% | 139 |
|
|
2015
Q2 | $28.2M | Sell |
243,488
-758,959
| -76% | -$86.8M | 0.15% | 140 |
|
|
2015
Q1 | $116M | Sell |
1,002,447
-22,709
| -2% | -$2.71M | 0.58% | 33 |
|
|
2014
Q4 | $115M | Sell |
1,025,156
-125,923
| -11% | -$13.3M | 0.54% | 33 |
|
|
2014
Q3 | $109M | Buy |
1,151,079
+262,762
| +30% | +$23.7M | 0.63% | 34 |
|
|
2014
Q2 | $76.3M | Buy |
888,317
+536,595
| +153% | +$40.8M | 0.39% | 54 |
|
|
2014
Q1 | $24.6M | Sell |
351,722
-1,840
| -0.5% | -$146K | 0.13% | 173 |
|
|
2013
Q4 | $29.9M | Sell |
353,562
-70,272
| -17% | -$5.56M | 0.15% | 154 |
|
|
2013
Q3 | $32.7M | Sell |
423,834
-499,852
| -54% | -$35M | 0.16% | 141 |
|
|
2013
Q2 | $54M | Buy |
+923,686
| New | +$55.6M | 0.29% | 96 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
ING Group's CELG Position: Q4 2019 in Review
ING Group sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 47,412 shares — an estimated $4.71M sold.
ING Group first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $116M in Q1 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- ING Group reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- ING Group sold 47,412 Celgene Corp shares in Q4 2019, an estimated $4.71M.
- ING Group first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- ING Group's Celgene Corp position peaked at $116M in Q1 2015.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on ING Group's 13F filing for Q4 2019, filed 10 Feb 2020.